Anavex Life Sciences (AVXL) Shares Issued (2010 - 2025)
Anavex Life Sciences recorded quarterly Shares Issued of $1.3 million in Q3 2025, up 962.18% quarter-over-quarter from $119000.0 in Q2 2025, and up 1320.22% year-over-year from $89000.0 in Q3 2024.
Anavex Life Sciences' Shares Issued history runs 15 years deep, the most recent figure standing at $1.3 million for Q3 2025.
- In Q3 2025, Shares Issued rose 1320.22% year-over-year to $1.3 million; the TTM figure through Sep 2025 stood at $2.9 million (up 325.9% YoY), while the FY2025 annual figure was $2.9 million, up 325.9% from the prior year.
- Shares Issued came in at $1.3 million for Q3 2025 at Anavex Life Sciences, up from $119000.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $17.9 million in Q1 2023 to a low of -$25.2 million in Q1 2021.
- A 5-year average of -$827127.3 and a median of $373497.0 in 2021 frame the typical range for Shares Issued.
- On a YoY basis, Shares Issued climbed as much as 456942.11% in 2023 and fell as far as 3459.85% in 2023.
- Anavex Life Sciences' Shares Issued stood at $373497.0 in 2021, then tumbled by 30.92% to $258000.0 in 2022, then plunged by 77.13% to $59000.0 in 2023, then surged by 1100.0% to $708000.0 in 2024, then surged by 78.53% to $1.3 million in 2025.
- According to Business Quant data, Shares Issued over the past three periods registered $1.3 million, $119000.0, and $852000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.26 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 119,000.00 |
| Jun 30, 2025 | 119,000.00 |
| Mar 31, 2025 | 852,000.00 |
| Mar 31, 2025 | 852,000.00 |
| Dec 31, 2024 | 708,000.00 |
| Dec 31, 2024 | 708,000.00 |
| Sep 30, 2024 | 89,000.00 |
| Sep 30, 2024 | 89,000.00 |
| Jun 30, 2024 | 444,000.00 |
| Jun 30, 2024 | 444,000.00 |
| Mar 31, 2024 | 99,000.00 |
| Mar 31, 2024 | 99,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Sep 30, 2023 | 868,000.00 |
| Sep 30, 2023 | 868,000.00 |
| Jun 30, 2023 | -17.25 Mn |
| Jun 30, 2023 | -17.25 Mn |
| Mar 31, 2023 | 17.90 Mn |
| Mar 31, 2023 | 17.90 Mn |
| Dec 31, 2022 | 258,000.00 |
| Dec 31, 2022 | 258,000.00 |
| Sep 30, 2022 | -190.00 |
| Sep 30, 2022 | -190.00 |
| Jun 30, 2022 | 513,267.00 |
| Jun 30, 2022 | 513,267.00 |
| Mar 31, 2022 | 123,426.00 |
| Mar 31, 2022 | 123,426.00 |
| Dec 31, 2021 | 373,497.00 |
| Dec 31, 2021 | 373,497.00 |
| Sep 30, 2021 | 2.24 Mn |
| Sep 30, 2021 | 2.24 Mn |
| Jun 30, 2021 | 869,606.00 |
| Jun 30, 2021 | 869,606.00 |
| Mar 31, 2021 | -25.24 Mn |
| Mar 31, 2021 | -25.24 Mn |
| Dec 31, 2020 | 26.24 Mn |
| Dec 31, 2020 | 26.24 Mn |
| Sep 30, 2020 | 8.26 Mn |
| Sep 30, 2020 | 8.26 Mn |
| Jun 30, 2020 | 20.49 Mn |
| Jun 30, 2020 | 20.49 Mn |
| Mar 31, 2020 | -11.00 Mn |
| Mar 31, 2020 | -11.00 Mn |
| Dec 31, 2019 | 11.00 Mn |
| Dec 31, 2019 | 11.00 Mn |
| Sep 30, 2019 | 3.47 Mn |
| Sep 30, 2019 | 3.47 Mn |
| Jun 30, 2019 | 9.29 Mn |
| Jun 30, 2019 | 9.29 Mn |
| Mar 31, 2019 | 3.07 Mn |
| Mar 31, 2019 | 3.07 Mn |
| Dec 31, 2018 | 1.99 Mn |
| Dec 31, 2018 | 1.99 Mn |
| Sep 30, 2018 | 1.21 Mn |
| Sep 30, 2018 | 1.21 Mn |
| Mar 31, 2018 | 459,850.00 |
| Mar 31, 2018 | 459,850.00 |
| Dec 31, 2017 | 4.23 Mn |
| Dec 31, 2017 | 4.23 Mn |
| Sep 30, 2017 | 4.84 Mn |
| Sep 30, 2017 | 4.84 Mn |
| Jun 30, 2017 | 4.42 Mn |
| Jun 30, 2017 | 4.42 Mn |
| Dec 31, 2015 | 125,060.00 |
| Dec 31, 2015 | 125,060.00 |
| Sep 30, 2015 | 8.76 Mn |
| Sep 30, 2015 | 8.76 Mn |
| Jun 30, 2015 | 3.08 Mn |
| Jun 30, 2015 | 3.08 Mn |
| Dec 31, 2014 | 500,000.00 |
| Dec 31, 2014 | 500,000.00 |
| Jun 30, 2014 | -30,000.00 |
| Jun 30, 2014 | -30,000.00 |
| Mar 31, 2014 | 210,000.00 |
| Mar 31, 2014 | 210,000.00 |
| Dec 31, 2013 | 188,170.00 |
| Dec 31, 2013 | 188,170.00 |
| Sep 30, 2013 | 801,285.00 |
| Sep 30, 2013 | 801,285.00 |
| Mar 31, 2012 | 283,750.00 |
| Mar 31, 2012 | 283,750.00 |
| Dec 31, 2011 | 712,500.00 |
| Dec 31, 2011 | 712,500.00 |
| Sep 30, 2011 | -65,363.00 |
| Sep 30, 2011 | -65,363.00 |
| Jun 30, 2011 | 1.68 Mn |
| Jun 30, 2011 | 1.68 Mn |
| Mar 31, 2011 | 228,800.00 |
| Mar 31, 2011 | 228,800.00 |
| Dec 31, 2010 | 1.18 Mn |
| Dec 31, 2010 | 1.18 Mn |
| Sep 30, 2010 | 433,126.00 |
| Sep 30, 2010 | 433,126.00 |